News summary

Muna oral pill shifts aging brain markers in trial

Source: Longevity Technology • Published: 03 Nov 2026, 15:53

Summarized by Masters of Longevity from Longevity Technology.

An oral TREM2 agonist moved elderly CSF markers toward younger patterns.

Muna oral pill shifts aging brain markers in trial
Key Takeaways
  • MNA-001 reached the brain with dose-related CNS exposure.
  • Soluble TREM2 in CSF and plasma fell with higher doses.
  • Repeated dosing shifted elderly microglial and stress markers toward younger.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.